Suppr超能文献

肠肽酶的全球现状与趋势:一项文献计量学研究

The Global Status and Trends of Enteropeptidase: A Bibliometric Study.

作者信息

Yang Xiaoli, Yin Hua, Peng Lisi, Zhang Deyu, Li Keliang, Cui Fang, Xia Chuanchao, Huang Haojie, Li Zhaoshen

机构信息

Department of Clinical Medicine, Ningxia Medical University, Yinchuan, China.

Shanghai Pudong New Area Gongli Hospital, Shanghai, China.

出版信息

Front Med (Lausanne). 2022 Feb 10;9:779722. doi: 10.3389/fmed.2022.779722. eCollection 2022.

Abstract

BACKGROUND

Enteropeptidase (EP) is a type II transmembrane serine protease and a physiological activator of trypsinogen. Extensive studies related to EP have been conducted to date. However, no bibliometric analysis has systematically investigated this theme. Our study aimed to visualize the current landscape and frontier trends of scientific achievements on EP, provide an overview of the past 120 years and insights for researchers and clinicians to facilitate future collaborative research and clinical intervention.

METHODS

Quantitative analysis of publications relating to EP from 1900 to 2020 was interpreted and graphed through the Science Citation Index Expanded of Web of Science Core Collection (limited to SCIE). Microsoft office 2019, GraphPad Prism 8, VOSviewer, and R-bibliometrix were used to conduct the bibliometric analysis.

RESULTS

From 1900 to 2020, a total of 1,034 publications were retrieved. The USA had the largest number of publications, making the greatest contribution to the topic ( = 260, 25.15%). Active collaborations between countries/regions were also enrolled. Grant and Hermontaylor were perhaps the most impactful researchers in the landscape of EP. and the were the most prevalent (79/1,034, 7.64%) and cited journals ( = 2,626), respectively. Using the top 15 citations and co-citations achievements clarified the theoretical basis of the EP research field. Important topics mainly include the structure of EP, the affective factors for activating substrates by EP, EP-related disorders, and inhibitors of EP.

CONCLUSION

Based on the bibliometric analysis, we have gained a comprehensive analysis of the global status and research frontiers of studies investigating EP, which provides some guidance and reference for researchers and clinicians engaged in EP research.

摘要

背景

肠肽酶(EP)是一种II型跨膜丝氨酸蛋白酶,也是胰蛋白酶原的生理激活剂。迄今为止,已经开展了大量与肠肽酶相关的研究。然而,尚无文献计量分析对该主题进行系统研究。我们的研究旨在可视化肠肽酶科学成果的当前格局和前沿趋势,概述过去120年的情况,并为研究人员和临床医生提供见解,以促进未来的合作研究和临床干预。

方法

通过Web of Science核心合集的科学引文索引扩展版(仅限于SCIE)对1900年至2020年与肠肽酶相关的出版物进行定量分析,并绘制图表。使用Microsoft office 2019、GraphPad Prism 8、VOSviewer和R-bibliometrix进行文献计量分析。

结果

1900年至2020年,共检索到1034篇出版物。美国的出版物数量最多,对该主题的贡献最大(n = 260,25.15%)。还纳入了国家/地区之间的积极合作情况。Grant和Hermontaylor可能是肠肽酶领域最具影响力的研究人员。《生物化学杂志》和《细胞》分别是最常见的(79/1034,7.64%)和被引频次最高的期刊(n = 2626)。利用前15名的被引和共被引成果阐明了肠肽酶研究领域的理论基础。重要主题主要包括肠肽酶的结构、肠肽酶激活底物的影响因素、与肠肽酶相关的疾病以及肠肽酶抑制剂。

结论

基于文献计量分析,我们对全球肠肽酶研究的现状和研究前沿有了全面的分析,这为从事肠肽酶研究的研究人员和临床医生提供了一些指导和参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af65/8866687/f431e5279c06/fmed-09-779722-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验